FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/12/038916 [Registered on: 24/12/2021] Trial Registered Prospectively
Last Modified On: 25/12/2021
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A study to see if adding magnesium sulphate to local anaesthetic in abdominal block decreases pain after gall bladder surgery 
Scientific Title of Study   Magnesium sulphate as adjuvant to ropivacaine in bilateral transversus abdominis plane block for laproscopic cholecystectomy. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Wasim Mohammad Bhat 
Designation  Lecturer Anaesthesiology 
Affiliation  SKIMS Medical College Bemina  
Address  Department of Anaesthesia, SKIMS Medical College Bemina,Srinagar, J & K,India

Srinagar
JAMMU & KASHMIR
190018
India 
Phone  7006142879  
Fax  0194-2490071  
Email  wmb914@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Wasim Mohammad Bhat 
Designation  Lecturer Anaesthesiology 
Affiliation  SKIMS Medical College Bemina  
Address  Department of Anaesthesia, SKIMS Medical College Bemina,Srinagar, J & K,India

Srinagar
JAMMU & KASHMIR
190018
India 
Phone  7006142879  
Fax  0194-2490071  
Email  wmb914@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Wasim Mohammad Bhat 
Designation  Lecturer Anaesthesiology 
Affiliation  SKIMS Medical College Bemina  
Address  Department of Anaesthesia, SKIMS Medical College Bemina,Srinagar, J & K,India

Srinagar
JAMMU & KASHMIR
190018
India 
Phone  7006142879  
Fax  0194-2490071  
Email  wmb914@gmail.com  
 
Source of Monetary or Material Support  
Department of Anaesthesia, Skims Medical College Hospital,Bemina, Srinagar 190018, J & K, India 
 
Primary Sponsor  
Name  Govt SKIMS Medical College Hospital 
Address  SKIMS Medical College Hospital Bemina Srinagar J and K India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Wasim Mohammad Bhat  Skims Medical College Hospital Bemina  Department of Anaesthesia, General Surgery Operation Room
Srinagar
JAMMU & KASHMIR 
7006868235

wmb914@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Skims Medical College Bemina Srinagar  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K802||Calculus of gallbladder without cholecystitis, (2) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Ultrasound guided subcostal TAP block will performed on both sides using 20 ml volume (19.5 ml of 0.2 % ropivacaine plus 0.5 ml Magnesium sulphate 50%)  Drug: Ropivacaine plus Magnesium sulphate.Ultrasound guided subcostal TAP block will performed on both sides using 20 ml volume (19.5 ml of 0.2 % ropivacaine plus 0.5 ml of 50 % Magnesium sulphate) Total duration of therapy will be 2 to 5 minutes. 
Comparator Agent  Ultrasound guided subcostal TAP block will performed on both sides using 20 ml volume (19.5 ml of 0.2 % ropivacaine plus 0.5 ml NS).   Drug: Ropivacaine +Normal saline. Ultrasound guided subcostal TAP block will performed on both sides using 20 ml volume (19.5 ml of 0.2 % ropivacaine plus 0.5 ml Normal saline). Total duration of therapy will be 2 to 5 minutes. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Adult patients aged 18-65 years undergoing laparoscopic cholecystectomy 
 
ExclusionCriteria 
Details  1.Patient refusal
2.Patients with a history of cardiac, or respiratory diseases (>ASA III).
3.Patients with allergy to amide local anesthetics or medication included in the study.
4.Infection at the needle insertion site.
5.Pregnancy
6.BMI >35
7.Drug abusers
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded 
Primary Outcome  
Outcome  TimePoints 
The post-operative pain during first 24 hours after surgery using Visual analogue scale.  24 hours 
 
Secondary Outcome  
Outcome  TimePoints 
1. Time to first dose of post-operative analgesia and total diclofenac consumption in 24 hours
2. Post-operative nausea and vomiting
3. Sedation
4. Patient satisfaction
 
24 hours 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/01/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Yet Recruiting 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study is a prospective randomised controlled trial to assess the effect  of adding magnesium sulphate  as adjuvant to ropivacaine in ultrasound guided transversus abdominis plane block in laproscopic cholecystectomy.The study is planned for 80 patients.The primary outcome measure is post-operative pain during the first 24 hours after surgery using visual analogue scale.Secondary outcome measures are time to first dose of post-operative analgesia and total diclofenac consumption in 24 hours, post-operative nausea and vomiting,sedation,patient satisfaction. 
Close